| 000 | 01657 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513141420.0 | ||
| 264 | 0 | _c19980414 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0165-0327 | ||
| 024 | 7 |
_a10.1016/s0165-0327(97)00107-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMittmann, N | |
| 245 | 0 | 0 |
_aThe efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. _h[electronic resource] |
| 260 |
_bJournal of affective disorders _cDec 1997 |
||
| 300 |
_a191-217 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntidepressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntidepressive Agents, Second-Generation _xtherapeutic use |
| 650 | 0 | 4 |
_aAntidepressive Agents, Tricyclic _xtherapeutic use |
| 650 | 0 | 4 |
_aDepressive Disorder _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aPatient Dropouts |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHerrmann, N | |
| 700 | 1 | _aEinarson, T R | |
| 700 | 1 | _aBusto, U E | |
| 700 | 1 | _aLanctôt, K L | |
| 700 | 1 | _aLiu, B A | |
| 700 | 1 | _aShulman, K I | |
| 700 | 1 | _aSilver, I L | |
| 700 | 1 | _aNarango, C A | |
| 700 | 1 | _aShear, N H | |
| 773 | 0 |
_tJournal of affective disorders _gvol. 46 _gno. 3 _gp. 191-217 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-0327(97)00107-9 _zAvailable from publisher's website |
| 999 |
_c9514558 _d9514558 |
||